Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: hotlinktuna who wrote (113332)	9/6/2000 11:55:12 AM
From: Lane Hall-Witt	Read Replies (1) \| Respond to of 120523

I'm expecting the biotechs to pull back here for a couple of weeks -- through earnings pre-announcement -- just to let off some team after the huge rally of late. MLNM is an awfully nice one. ABGX is my favorite trader. I've also been re-accumulating ORTC, a chronic underperformer in the biotech space, in anticipation of FDA product approvals expected by calendar year-end. Gonna go out and hit some golf balls. See you later this afternoon!

To: hotlinktuna who wrote (113332)	9/6/2000 11:58:20 AM
From: Norm Demers	Respond to of 120523

September 6, 2000 11:21am Surprise! RSA releases crypto patent ahead of schedule By Scott Berinato eWEEK RSA Security Inc. (Nasdaq: RSAS) today pulled the tablecloth from underneath its competitors' plates, releasing its cryptographic algorithm into the public domain two weeks early. The patent on RSA's crypto technology, which is widely employed in the security realm, would have expired September 20, exactly 17 years after the patent was issued to the Massachusetts Institute of Technology and licensed exclusively to RSA. The 20th has been widely considered a watershed date, circled on the calendards of many security company executives' calendars. Some companies, like Baltimore Technologies Inc., were using the expiration of the patent as a springboard for new products and marketing campaigns. RSA CEO Art Coviello told eWEEK that the company wanted to get this milestone out of the way because it was garnering too much attention and confusing customers. "Someone asked me if I had thought about extending the patent, and that's the thing," Coviello said. "The idea of extending the patent hadn't even occurred to us because it's just not part of our business. Why would we not want this to be the de facto standard in the public domain? So now it's out there." Coviello also said that the expiration of patent number 4,405,829 hasn't affected the company's strategic direction, which appears to remain focused on technology. While other companies are hurriedly extending into managed security services, RSA wants to remain a company entrenched in code. "We're not schizophrenic," Coviello said. "We know who we are. We won't try to be something we're not. I don't think you can execute on a managed services model and a product model at the same time."